Oncolytics Biotech (ONCY) Equity Income (2014 - 2025)
Oncolytics Biotech (ONCY) posted quarterly Equity Income of $141295.0 for Q1 2016, up 146.3% year-over-year from $57366.4 in Q2 2015, and up 146.3% quarter-over-quarter from -$305156.0 in Q4 2015.
Oncolytics Biotech (ONCY) Equity Income (2014 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Equity Income for 3 consecutive years, with $141295.0 the latest figure, recorded in Q1 2016.
- In Q1 2016, Equity Income rose 146.3% year-over-year to $141295.0; the TTM figure through Mar 2016 stood at -$444947.0 (changed N/A YoY), while the FY2025 annual figure was -$388000.0, changed N/A from the prior year.
- Equity Income improved to $141295.0 in Q1 2016 per ONCY's latest filing, from -$305156.0 in the prior quarter.
- Across five years, Equity Income topped out at $141295.0 in Q1 2016 and bottomed at -$305156.0 in Q1 2015.
- Historically, Equity Income has averaged -$84175.4 across 3 years, with a median of $24070.0 in 2014.
- Annual changes were most pronounced in 2015 — Equity Income tumbled 1367.79% — and 2016, when it surged 146.3%.
- Oncolytics Biotech's Equity Income stood at $24070.0 in 2014, then sank by 1367.79% to -$305156.0 in 2015, then soared by 146.3% to $141295.0 in 2016.
- Business Quant data shows ONCY's Equity Income at $141295.0 in Q1 2016, -$305156.0 in Q4 2015, and -$305156.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.08 Mn |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -388,000.00 |
| Mar 31, 2016 | 141,295.00 |
| Dec 31, 2015 | -305,156.00 |
| Mar 31, 2015 | -305,156.00 |
| Dec 31, 2014 | 24,070.00 |
| Mar 31, 2014 | 24,070.00 |